We found that SOCS5 stimulates the promoter of SREBP1 by interacting with RBMX, inducing de novo lipogenesis to promote HCC metastasis, while mutations in the SH2 domain, Y413, and D443 reverse this effect. The gene discussed is SOCS5; the disease is hepatocellular carcinoma.